jan m. Van Ree, PhD - Publications

Affiliations: 
Pharmacology University Medical Center Utrecht, Utrecht, Netherlands 
Area:
addiction, psychiatry
Website:
http://profs.library.uu.nl/index.php/profrec/getprofdata/1694/22/135/0

242 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Randesi M, van den Brink W, Levran O, Blanken P, van Ree JM, Ott J, Kreek MJ. VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence. Pharmacogenomics. PMID 30983500 DOI: 10.2217/pgs-2018-0137  0.56
2018 Randesi M, van den Brink W, Levran O, Yuferov V, Blanken P, van Ree JM, Ott J, Kreek MJ. Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls. Pharmacogenomics. 19: 95-104. PMID 29210332 DOI: 10.2217/pgs-2017-0134  0.56
2016 Randesi M, van den Brink W, Levran O, Blanken P, Butelman ER, Yuferov V, da Rosa JC, Ott J, van Ree JM, Kreek MJ. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. Drug and Alcohol Dependence. 168: 164-169. PMID 27664554 DOI: 10.1016/j.drugalcdep.2016.08.634  0.56
2016 Blanken P, Hendriks VM, Huijsman IA, van Ree JM, van den Brink W. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial. Drug and Alcohol Dependence. PMID 27177805 DOI: 10.1016/j.drugalcdep.2016.04.018  0.56
2014 Zaaijer ER, Bruijel J, Blanken P, Hendriks V, Koeter MW, Kreek MJ, Booij J, Goudriaan AE, van Ree JM, van den Brink W. Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. Drug and Alcohol Dependence. 145: 101-5. PMID 25454407 DOI: 10.1016/j.drugalcdep.2014.09.783  0.56
2012 Nutt DJ, Ove Ögren S, van Ree JM. Neuropsychopharmacology across brain diseases. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 844-6. PMID 23121859 DOI: 10.1016/j.euroneuro.2012.10.001  1
2012 Chen AC, Theuvenet PJ, de Munck JC, Peters MJ, van Ree JM, Lopes da Silva FL. Sensory handedness is not reflected in cortical responses after basic nerve stimulation: a MEG study. Brain Topography. 25: 228-40. PMID 22080222 DOI: 10.1007/s10548-011-0209-7  1
2012 Blanken P, Hendriks VM, Koeter MW, van Ree JM, van den Brink W. Craving and illicit heroin use among patients in heroin-assisted treatment. Drug and Alcohol Dependence. 120: 74-80. PMID 21782351 DOI: 10.1016/j.drugalcdep.2011.06.025  1
2011 Theuvenet PJ, de Munck JC, Peters MJ, van Ree JM, Lopes da Silva FL, Chen AC. Anesthetic block of pain-related cortical activity in patients with peripheral nerve injury measured by magnetoencephalography. Anesthesiology. 115: 375-86. PMID 21685789 DOI: 10.1097/ALN.0b013e31821f6562  1
2011 Buster MC, van den Brink W, van Brussel GH, van Ree JM. Influence of treatment with inhalable heroin on pulmonary function. European Addiction Research. 17: 136-8. PMID 21422758 DOI: 10.1159/000324482  1
2010 Blanken P, van den Brink W, Hendriks VM, Huijsman IA, Klous MG, Rook EJ, Wakelin JS, Barendrecht C, Beijnen JH, van Ree JM. Heroin-assisted treatment in the Netherlands: History, findings, and international context. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: S105-58. PMID 20362236 DOI: 10.1016/S0924-977X(10)70001-8  1
2010 Blanken P, Hendriks VM, van Ree JM, van den Brink W. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands. Addiction (Abingdon, England). 105: 300-8. PMID 19922517 DOI: 10.1111/j.1360-0443.2009.02754.x  1
2009 Buisman-Pijlman FT, Gerrits MA, Van Ree JM. Increased opioid release in specific brain areas in animals exposed to prenatal morphine and emotional stress later in life. Neuroscience. 159: 405-13. PMID 19138727 DOI: 10.1016/j.neuroscience.2008.11.010  1
2009 de Krom M, Staal WG, Ophoff RA, Hendriks J, Buitelaar J, Franke B, de Jonge MV, Bolton P, Collier D, Curran S, van Engeland H, van Ree JM. A common variant in DRD3 receptor is associated with autism spectrum disorder. Biological Psychiatry. 65: 625-30. PMID 19058789 DOI: 10.1016/j.biopsych.2008.09.035  1
2009 Montgomery SA, van Ree JM. Farewell message from the Founding Editors European Neuropsychopharmacology. 19: 609. DOI: 10.1016/j.euroneuro.2009.06.013  1
2008 Kas MJ, de Mooij-van Malsen AJ, Olivier B, Spruijt BM, van Ree JM. Differential genetic regulation of motor activity and anxiety-related behaviors in mice using an automated home cage task. Behavioral Neuroscience. 122: 769-76. PMID 18729629 DOI: 10.1037/0735-7044.122.4.769  1
2008 van Ree JM, Breimer DD. Pharmacology in The Netherlands: past, present and future. Trends in Pharmacological Sciences. 29: 167-9. PMID 18355928 DOI: 10.1016/j.tips.2008.01.009  1
2008 Jager G, de Win MM, van der Tweel I, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 247-58. PMID 17460617 DOI: 10.1038/sj.npp.1301415  1
2008 Van Ree JM, Bohus B, Csontos KM, Gispen WH, Greven HM, Nijkamp FP, Opmeer FA, de Rotte GAA, Van Wimersma Greidanus TB, Witter A, de Wied D. γ -Melanotropin and Brain Function Peptides of the Pars Intermedia. 263-276. DOI: 10.1002/9780470720646.ch15  1
2007 Jager G, de Win MM, Vervaeke HK, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study. Psychopharmacology. 193: 403-14. PMID 17476480 DOI: 10.1007/s00213-007-0792-1  1
2007 Jager G, Van Hell HH, De Win MM, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 289-97. PMID 17137758 DOI: 10.1016/j.euroneuro.2006.10.003  1
2007 Bouwmeester H, Gerrits MA, Roozemond JG, Snapper J, Ronken E, Kruse CG, Westenberg HG, van Ree JM. Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 727-39. PMID 17076936 DOI: 10.1017/S1461145706007346  1
2007 van der Zanden BP, Dijkgraaf MG, Blanken P, van Ree JM, van den Brink W. Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment. Drug and Alcohol Dependence. 86: 84-90. PMID 16806740 DOI: 10.1016/j.drugalcdep.2006.05.021  1
2007 Klous MG, Nuijen B, Van Den Brink W, Van Ree JM, Beijnen JH. Pharmaceutical development of dosage forms of diamorphine for use by heroin addicts | Farmaceutische ontwikkeling van toedieningsvormen van diacetylmorfine voor heroïneverslaafden Pharmaceutisch Weekblad. 142: 98-104.  1
2006 Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Current Clinical Pharmacology. 1: 109-18. PMID 18666382 DOI: 10.2174/157488406775268219  1
2006 Theuvenet PJ, van Dijk BW, Peters MJ, van Ree JM, Lopes da Silva FL, Chen AC. Cortical characterization and inter-dipole distance between unilateral median versus ulnar nerve stimulation of both hands in MEG. Brain Topography. 19: 29-42. PMID 16977490 DOI: 10.1007/s10548-006-0010-1  1
2006 Rook EJ, Huitema AD, van den Brink W, Hillebrand MJ, van Ree JM, Beijnen JH. Screening for illicit heroin use in patients in a heroin-assisted treatment program. Journal of Analytical Toxicology. 30: 390-4. PMID 16872571  1
2006 Rook EJ, van Zanten AP, Van den Brink W, van Ree JM, Beijnen JH. Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin. Drug and Alcohol Dependence. 85: 185-90. PMID 16765536 DOI: 10.1016/j.drugalcdep.2006.04.013  1
2006 Klous MG, Lee WC, Van den Brink W, Van Ree JM, Beijnen JH. Volatilisation of diacetylmorphine: in vitro simulation of 'chasing the dragon'. Die Pharmazie. 61: 438-45. PMID 16724542  1
2006 Klous MG, Lee W, Hillebrand MJ, van den Brink W, van Ree JM, Beijnen JH. Analysis of diacetylmorphine, caffeine, and degradation products after volatilization of pharmaceutical heroin for inhalation. Journal of Analytical Toxicology. 30: 6-13. PMID 16620525  1
2006 Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Population pharmacokinetics of heroin and its major metabolites. Clinical Pharmacokinetics. 45: 401-17. PMID 16584286 DOI: 10.2165/00003088-200645040-00005  1
2006 Kudryavtseva N, Gerrits MA, Avgustinovich DF, Tenditnik MV, Van Ree JM. Anxiety and ethanol consumption in victorious and defeated mice; effect of kappa-opioid receptor activation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 504-11. PMID 16524701 DOI: 10.1016/j.euroneuro.2006.01.002  1
2006 Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology. 185: 358-68. PMID 16521034 DOI: 10.1007/s00213-005-0298-7  1
2006 Van den Brink W, Montgomery SA, Van Ree JM, van Zwieten-Boot BJ. ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 224-30. PMID 16442270 DOI: 10.1016/j.euroneuro.2005.12.003  1
2006 Rook EJ, van Ree JM, van den Brink W, Hillebrand MJ, Huitema AD, Hendriks VM, Beijnen JH. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic & Clinical Pharmacology & Toxicology. 98: 86-96. PMID 16433897 DOI: 10.1111/j.1742-7843.2006.pto_233.x  1
2006 Hogen Esch AJ, van der Heide S, van den Brink W, van Ree JM, Bruynzeel DP, Coenraads PJ. Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine). Contact Dermatitis. 54: 42-9. PMID 16426293 DOI: 10.1111/j.0105-1873.2006.00745.x  1
2006 Gerrits MA, Wolterink G, van Ree JM. Cerebral metabolic consequences in the adult brain after neonatal excitotoxic lesions of the amygdala in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 358-65. PMID 16356694 DOI: 10.1016/j.euroneuro.2005.11.005  1
2006 van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van den Brink W. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug and Alcohol Dependence. 82: 111-8. PMID 16168573 DOI: 10.1016/j.drugalcdep.2005.08.012  1
2005 Kudryavtseva NN, Gerrits MA, Alekseenko OV, Van Ree JM. Chronic cocaine injections attenuate behavioral response of kappa-opioid receptors to U-50,488H agonist. Bulletin of Experimental Biology and Medicine. 140: 320-2. PMID 16307048 DOI: 10.1007/s10517-005-0479-8  1
2005 Klous MG, Rook EJ, Hillebrand MJ, van den Brink W, van Ree JM, Beijnen JH. Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program. Journal of Analytical Toxicology. 29: 564-9. PMID 16168180  1
2005 Lekkerkerker JF, Schobben AF, van Dissel JT, Hekster YA, Hoes AW, Mulder GJ, Neef C, Peeters MF, van Ree JM, Rosmalen CF, Schellekens H, Schellens JH, Silberbusch J. [Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression]. Nederlands Tijdschrift Voor Geneeskunde. 149: 1870-1; author reply. PMID 16128186  1
2005 Rook EJ, Hillebrand MJ, Rosing H, van Ree JM, Beijnen JH. The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 824: 213-21. PMID 16103023 DOI: 10.1016/j.jchromb.2005.05.048  1
2005 Theuvenet PJ, van Dijk BW, Peters MJ, van Ree JM, Lopes da Silva FL, Chen AC. Whole-head MEG analysis of cortical spatial organization from unilateral stimulation of median nerve in both hands: no complete hemispheric homology. Neuroimage. 28: 314-25. PMID 16040256 DOI: 10.1016/j.neuroimage.2005.06.010  1
2005 Klous MG, Bronner GM, Nuijen B, van Ree JM, Beijnen JH. Pharmaceutical heroin for inhalation: thermal analysis and recovery experiments after volatilisation. Journal of Pharmaceutical and Biomedical Analysis. 39: 944-50. PMID 16039820 DOI: 10.1016/j.jpba.2005.06.011  1
2005 Van Ree JM, Schagen Van Leeuwen JH, Koppeschaar HP, Te Velde ER. Unexpected placebo response in premenstrual dysphoric disorder: implication of endogenous opioids. Psychopharmacology. 182: 318-9. PMID 16001107 DOI: 10.1007/s00213-005-0090-8  1
2005 Diergaarde L, Spruijt BM, Wolterink-Donselaar IG, Gerrits MA, van Ree JM. Neonatal amygdala lesions affect appetitive motivational and consummatory aspects of social behavior in the rat. Behavioral Neuroscience. 119: 814-20. PMID 15998203 DOI: 10.1037/0735-7044.119.3.814  1
2005 Dijkgraaf MG, van der Zanden BP, de Borgie CA, Blanken P, van Ree JM, van den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. Bmj (Clinical Research Ed.). 330: 1297. PMID 15933353 DOI: 10.1136/bmj.330.7503.1297  1
2005 Klous MG, Van den Brink W, Van Ree JM, Beijnen JH. Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients. Drug and Alcohol Dependence. 80: 283-95. PMID 15916865 DOI: 10.1016/j.drugalcdep.2005.04.008  0.56
2005 Goloshchapov AV, Filipenko ML, Bondar NP, Kudryavtseva NN, Van Ree JM. Decrease of kappa-opioid receptor mRNA level in ventral tegmental area of male mice after repeated experience of aggression. Brain Research. Molecular Brain Research. 135: 290-2. PMID 15857692 DOI: 10.1016/j.molbrainres.2004.11.009  1
2005 Gerrits MA, Kuzmin AV, van Ree JM. Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 15: 297-303. PMID 15820419 DOI: 10.1016/j.euroneuro.2004.11.004  1
2005 Klous MG, Huitema AD, Rook EJ, Hillebrand MJ, Hendriks VM, Van den Brink W, Beijnen JH, Van Ree JM. Pharmacokinetic comparison of two methods of heroin smoking: 'chasing the dragon' versus the use of a heating device. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 15: 263-9. PMID 15820414 DOI: 10.1016/j.euroneuro.2004.12.001  1
2005 Zandvliet AS, Huitema AD, de Jonge ME, den Hoed R, Sparidans RW, Hendriks VM, van den Brink W, van Ree JM, Beijnen JH. Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine. Basic & Clinical Pharmacology & Toxicology. 96: 71-9. PMID 15667599 DOI: 10.1111/j.1742-7843.2005.pto960111.x  1
2005 Mathon DS, Lesscher HM, Gerrits MA, Kamal A, Pintar JE, Schuller AG, Spruijt BM, Burbach JP, Smidt MP, van Ree JM, Ramakers GM. Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice. Neuroscience. 130: 359-67. PMID 15664692 DOI: 10.1016/j.neuroscience.2004.10.002  1
2005 Blanken P, Hendriks VM, Koeter MW, van Ree JM, van den Brink W. Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials. Addiction (Abingdon, England). 100: 89-95. PMID 15598196 DOI: 10.1111/j.1360-0443.2005.00937.x  1
2005 Diergaarde L, Gerrits MA, Brouwers JP, van Ree JM. Early amygdala damage disrupts performance on medial prefrontal cortex-related tasks but spares spatial learning and memory in the rat. Neuroscience. 130: 581-90. PMID 15590142 DOI: 10.1016/j.neuroscience.2004.09.022  1
2005 Lesscher HM, Hoogveld E, Burbach JP, van Ree JM, Gerrits MA. Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 15: 31-7. PMID 15572271 DOI: 10.1016/j.euroneuro.2004.04.003  1
2005 Lesscher HM, Hordijk M, Bondar NP, Alekseyenko OV, Burbach JP, van Ree JM, Gerrits MA. Mu-opioid receptors are not involved in acute cocaine-induced locomotor activity nor in development of cocaine-induced behavioral sensitization in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 278-85. PMID 15257307 DOI: 10.1038/sj.npp.1300529  1
2004 Klous MG, Nuijen B, van den Brink W, Van Ree JM, Beijnen JH. Pharmaceutical development of an intravenous dosage form of diacetylmorphine hydrochloride. Pda Journal of Pharmaceutical Science and Technology / Pda. 58: 287-95. PMID 15663060  1
2004 Klous MG, Nuijen B, van den Brink W, van Ree JM, Beijnen JH. Development and manufacture of diacetylmorphine/caffeine sachets for inhalation via 'chasing the dragon' by heroin addicts. Drug Development and Industrial Pharmacy. 30: 775-84. PMID 15491055 DOI: 10.1081/DDC-120040223  1
2004 Klous MG, Nuijen B, Van den Brink W, Van Ree JM, Beijnen JH. Process characterisation, optimisation and validation of production of diacetylmorphine/caffeine sachets: a design of experiments approach. International Journal of Pharmaceutics. 285: 65-75. PMID 15488680 DOI: 10.1016/j.ijpharm.2004.07.007  0.56
2004 Kudryavtseva NN, Gerrits MA, Avgustinovich DF, Tenditnik MV, Van Ree JM. Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice. Peptides. 25: 1355-63. PMID 15350704 DOI: 10.1016/j.peptides.2004.05.005  1
2004 Montgomery SA, Lecrubier Y, Baldwin DS, Kasper S, Lader M, Nil R, Stein D, Van Ree JM. ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 425-33. PMID 15336305 DOI: 10.1016/j.euroneuro.2004.06.001  1
2004 Kamphuis PJ, Croiset G, Bakker JM, Van Bel F, Van Ree JM, Wiegant VM. Neonatal dexamethasone treatment affects social behaviour of rats in later life. Neuropharmacology. 47: 461-74. PMID 15275835 DOI: 10.1016/j.neuropharm.2004.04.008  1
2004 Kas MJ, Van Ree JM. Dissecting complex behaviours in the post-genomic era. Trends in Neurosciences. 27: 366-9. PMID 15219734 DOI: 10.1016/j.tins.2004.04.011  1
2004 Diergaarde L, Gerrits MA, Stuy A, Spruijt BM, van Ree JM. Neonatal amygdala lesions and juvenile isolation in the rat: differential effects on locomotor and social behavior later in life. Behavioral Neuroscience. 118: 298-305. PMID 15113254 DOI: 10.1037/0735-7044.118.2.298  1
2004 Dehue T, Reed LJ, De Wet C, Bearn J, Craighead IB, Caplehorn J, Voth EA, Aeschbach E, Van Den Brink W, Blanken P, Hendriks VM, Koeter MWJ, Van Zwieten BJ, Van Ree JM. Prescription of heroin to treatment resistant heroin addicts [5] British Medical Journal. 328: 228-229. PMID 14739203  1
2003 Kudriavtseva NN, Dolgov VV, Koriakina LA, Romaneeva LG, Van Ree JM. [Involvement of kappa-opioid receptors in mechanisms of aggressive and submissive types of behavior in male mice]. RossiÄ­Skii FiziologicheskiÄ­ Zhurnal Imeni I.M. Sechenova / RossiÄ­Skaia Akademiia Nauk. 89: 982-91. PMID 15119194  1
2003 van den Brink W, van Ree JM. Pharmacological treatments for heroin and cocaine addiction. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 476-87. PMID 14636964 DOI: 10.1016/j.euroneuro.2003.08.008  1
2003 Gerrits MA, Lesscher HB, van Ree JM. Drug dependence and the endogenous opioid system. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 424-34. PMID 14636958 DOI: 10.1016/j.euroneuro.2003.08.003  1
2003 Spieksma RPW, Goppel MA, Van Den Brink W, Van Ree JM. Pharmacological interventions in drug addiction; An advice of the Netherlands Health Council [1] (multiple letters) | 'Medicamenteuze interventies bij drugverslaving'; een advies van de Gezondheidsraad Nederlands Tijdschrift Voor Geneeskunde. 147: 2085. PMID 14606357  1
2003 Goppel MA, van den Brink W, van Ree JM. ['Pharmacologic interventions in drug addiction': an advisory report from the Health Council of the Netherlands]. Nederlands Tijdschrift Voor Geneeskunde. 147: 1637-40. PMID 12966629  1
2003 Pijlman FT, Herremans AH, van de Kieft J, Kruse CG, van Ree JM. Behavioural changes after different stress paradigms: prepulse inhibition increased after physical, but not emotional stress. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 369-80. PMID 12957336 DOI: 10.1016/S0924-977X(03)00040-3  1
2003 van den Brink W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. Bmj (Clinical Research Ed.). 327: 310. PMID 12907482 DOI: 10.1136/bmj.327.7410.310  1
2003 Daenen EW, Wolterink G, Van Ree JM. Hyperresponsiveness to phencyclidine in animals lesioned in the amygdala on day 7 of life. Implications for an animal model of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 273-9. PMID 12888187 DOI: 10.1016/S0924-977X(03)00029-4  1
2003 Terpstra J, Gispen-De Wied CC, Broekhoven MH, Frankhuijzen AC, Kahn RS, van Ree JM, Wiegant VM. Attenuated stress responsiveness in an animal model for neurodevelopmental psychopathological disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 249-56. PMID 12888184 DOI: 10.1016/S0924-977X(03)00010-5  1
2003 Daenen EW, Wolterink G, Van Der Heyden JA, Kruse CG, Van Ree JM. Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 187-97. PMID 12729945 DOI: 10.1016/S0924-977X(03)00007-5  1
2003 Bouwmeester H, Snapper J, Ronken E, Kruse CG, van Ree JM. Effects of neonatal amygdala lesions on [125I] neurotensin binding in specific brain areas of adult rat. The European Journal of Neuroscience. 17: 1319-22. PMID 12670322 DOI: 10.1046/j.1460-9568.2003.02606.x  1
2003 Lesscher HM, Bailey A, Burbach JP, Van Ree JM, Kitchen I, Gerrits MA. Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice. The European Journal of Neuroscience. 17: 1006-12. PMID 12653976 DOI: 10.1046/j.1460-9568.2003.02502.x  1
2003 Pijlman FT, Wolterink G, Van Ree JM. Physical and emotional stress have differential effects on preference for saccharine and open field behaviour in rats. Behavioural Brain Research. 139: 131-8. PMID 12642184 DOI: 10.1016/S0166-4328(02)00124-9  1
2003 Lesscher HM, Burbach JP, van Ree JM, Gerrits MA. ERK1/2 activation in rat ventral tegmental area by the mu-opioid agonist fentanyl: an in vitro study. Neuroscience. 116: 139-44. PMID 12535947 DOI: 10.1016/S0306-4522(02)00552-3  1
2003 Van Den Brink W, Goppel M, Van Ree JM. Management of opioid dependence Current Opinion in Psychiatry. 16: 297-304. DOI: 10.1097/00001504-200305000-00005  1
2003 Van Den Brink W, Van Ree JM. Treatment options for heroin and cocaine addiction European Neuropsychopharmacology. 13: S13-S15. DOI: 10.1016/S0924-977X(03)90010-1  1
2003 Gerrits MAFM, Van Ree JM. Endogenous opioids and drug dependence European Neuropsychopharmacology. 13: S4-S5. DOI: 10.1016/S0924-977X(03)90002-2  1
2003 Hendriks VM, Van Den Brink W, Blanken P, Koeter MWJ, Van Zwieten BJ, Van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials | Heroïne en methadon op medisch voorschrift voor chronisch, therapieresistente heroïneverslaafden: Twee gerandomiseerde studies Nederlands Tijdschrift Voor Geneeskunde. 147: 2065-2071.  1
2002 Daenen EW, Wolterink G, Gerrits MA, Van Ree JM. The effects of neonatal lesions in the amygdala or ventral hippocampus on social behaviour later in life. Behavioural Brain Research. 136: 571-82. PMID 12429419 DOI: 10.1016/S0166-4328(02)00223-1  1
2002 Pijlman FT, van Ree JM. Physical but not emotional stress induces a delay in behavioural coping responses in rats. Behavioural Brain Research. 136: 365-73. PMID 12429398 DOI: 10.1016/S0166-4328(02)00128-6  1
2002 Buster M, Rook L, van Brussel GH, van Ree J, van den Brink W. Chasing the dragon, related to the impaired lung function among heroin users. Drug and Alcohol Dependence. 68: 221-8. PMID 12234652 DOI: 10.1016/S0376-8716(02)00193-X  1
2002 Fischer B, Rehm J, Kirst M, Casas M, Hall W, Krausz M, Metrebian N, Reggers J, Uchtenhagen A, van den Brink W, van Ree JM. Heroin-assisted treatment as a response to the public health problem of opiate dependence. European Journal of Public Health. 12: 228-34. PMID 12232964 DOI: 10.1093/eurpub/12.3.228  1
2002 Bouwmeester H, Smits K, Van Ree JM. Neonatal development of projections to the basolateral amygdala from prefrontal and thalamic structures in rat Journal of Comparative Neurology. 450: 241-255. PMID 12209853 DOI: 10.1002/cne.10321  1
2002 Pijlman FT, Wolterink G, van Ree JM. Cueing unavoidable physical but not emotional stress increases long-term behavioural effects in rats. Behavioural Brain Research. 134: 393-401. PMID 12191826  0.68
2002 Hulshoff Pol HE, Hijman R, Tulleken CA, Heeren TJ, Schneider N, van Ree JM. Odor discrimination in patients with frontal lobe damage and Korsakoff's syndrome. Neuropsychologia. 40: 888-91. PMID 11900740  1
2002 Daenen EWPM, Wolterink G, Gerrits MAFM, Van Ree JM. Amygdala or ventral hippocampal lesions at two early stages of life differentially affect open field behaviour later in life; an animal model of neurodevelopmental psychopathological disorders Behavioural Brain Research. 131: 67-78. PMID 11844573 DOI: 10.1016/S0166-4328(01)00350-3  1
2002 Bouwmeester H, Wolterink G, Van Ree JM. Neonatal development of projections from the basolateral amygdala to prefrontal, striatal, and thalamic structures in the rat Journal of Comparative Neurology. 442: 239-249. PMID 11774339 DOI: 10.1002/cne.10084  1
2002 Gerrits MA, Petromilli P, Westenberg HG, Di Chiara G, van Ree JM. Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats. Brain Research. 924: 141-50. PMID 11750899 DOI: 10.1016/S0006-8993(01)03105-5  1
2002 Pijlman FTA, Wolterink G, Van Ree JM. Cueing unavoidable physical but not emotional stress increases long-term behavioural effects in rats Behavioural Brain Research. 134: 393-401. DOI: 10.1016/S0166-4328(02)00053-0  1
2001 Daenen EW, Van der Heyden JA, Kruse CG, Wolterink G, Van Ree JM. Adaptation and habituation to an open field and responses to various stressful events in animals with neonatal lesions in the amygdala or ventral hippocampus. Brain Research. 918: 153-65. PMID 11684053 DOI: 10.1016/S0006-8993(01)02987-0  1
2001 Souery D, Mendlewicz J, Lecrubier Y, Montgomery S, Van Ree J, Zohar J. Developing cross-national CME for mental disorders in Europe [1] European Psychiatry. 16: 255-256. PMID 11464809 DOI: 10.1016/S0924-9338(01)00573-9  1
2001 Hendriks VM, Van den Brink W, Blanken P, Bosman IJ, Van Ree JM. Heroin self-administration by means of 'chasing the dragon': Pharmacodynamics and bioavailability of inhaled heroin European Neuropsychopharmacology. 11: 241-252. PMID 11418285 DOI: 10.1016/S0924-977X(01)00091-8  1
2001 Reijmers LG, Hoekstra K, Burbach JP, van Ree JM, Spruijt BM. Long-term impairment of social memory in the rat after social defeat is not restored by desglycinamide-vasopressin. Neuroscience Letters. 305: 145-8. PMID 11403926 DOI: 10.1016/S0304-3940(01)01834-1  1
2001 Reijmers LG, Baars AM, Burbach JP, Spruijt BM, van Ree JM. Delayed effect of the vasopressin metabolite VP4-8 on the social memory of sexually naive male rats. Psychopharmacology. 154: 408-14. PMID 11349395 DOI: 10.1007/s002130000672  1
2001 Angst J, Bowden CL, Calabrese JR, Chengappa R, Goodwin G, Lecrubier Y, Licht R, Nlen WA, Sachs G, Saint Raymond A, Storosum J, Suppes P, Van Ree JM. ECNP consensus meeting March 2000: Nice guidelines for investigating efficacy in bipolar disorder European Neuropsychopharmacology. 11: 79-88. PMID 11300094 DOI: 10.1016/S0924-977X(00)00140-1  1
2001 Reijmers LG, Leus IE, Burbach JP, Spruijt BM, van Ree JM. Social memory in the rat: circadian variation and effect of circadian rhythm disruption. Physiology & Behavior. 72: 305-9. PMID 11274671 DOI: 10.1016/S0031-9384(00)00434-0  1
2001 Wolterink G, Daenen LE, Dubbeldam S, Gerrits MA, van Rijn R, Kruse CG, Van Der Heijden JA, Van Ree JM. Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 11: 51-9. PMID 11226812 DOI: 10.1016/S0924-977X(00)00138-3  1
2000 Kuzmin AV, Gerrits MAFM, Zvartau EE, Van Ree JM. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice European Neuropsychopharmacology. 10: 447-454. PMID 11115734 DOI: 10.1016/S0924-977X(00)00117-6  1
2000 Reijmers LG, Hernando F, van Ree JM, Spruijt BM, Burbach JP. Differential responses of phosphorylated mitogen-activated protein kinase and phosphorylated cyclic-AMP response element-binding protein immunoreactivity in the rat brain to sub-convulsive pentylenetetrazol. Neuroscience. 101: 1023-8. PMID 11113351 DOI: 10.1016/S0306-4522(00)00394-8  1
2000 Van Ree JM, Niesink RJ, Van Wolfswinkel L, Ramsey NF, Kornet MM, Van Furth WR, Vanderschuren LJ, Gerrits MA, Van den Berg CL. Endogenous opioids and reward. European Journal of Pharmacology. 405: 89-101. PMID 11033317 DOI: 10.1016/S0014-2999(00)00544-6  1
2000 Pol HEH, Van Der Flier WM, Schnack HG, Tulleken CAF, Ramos LM, Van Ree JM, Kahn RS. Frontal lobe damage and thalamic volume changes Neuroreport. 11: 3039-3041. PMID 11006990  1
2000 Hulshoff Pol HE, Hijman R, Baaré WFC, Van Eekelen S, Van Ree JM. Odor discrimination and task duration in young and older adults Chemical Senses. 25: 461-464. PMID 10944510  1
2000 Van Den Berg CL, Van Ree JM, Spruijt BM. Morphine attenuates the effects of juvenile isolation in rats Neuropharmacology. 39: 969-976. PMID 10727707 DOI: 10.1016/S0028-3908(99)00216-6  1
2000 Oranje B, Van Berckel BNM, Kemner C, Van Ree JM, Kahn RS, Verbaten MN. The effects of a sub-anaesthetic dose of ketamine on human selective attention Neuropsychopharmacology. 22: 293-302. PMID 10693157 DOI: 10.1016/S0893-133X(99)00118-9  1
2000 Van Den Brink W, Hendriks VM, Blanken P, Van Ree JM. The Dutch study on the effectiveness of medical prescription of heroin: Background, research design and first experiences | Het Nederlandse onderzoek naar de effectiviteit van heroine op medisch voorschrift; achtergronden, onderzoeksopzet en eerste ervaringen Nederlands Tijdschrift Voor Geneeskunde. 144: 108-112. PMID 10674115  1
2000 Wolterink G, Daenen EWPM, Van Ree JM. Animal models for schizophrenia Neuroscience Research Communications. 27: 143-154. DOI: 10.1002/1520-6769(200011/12)27:3<143::AID-NRC1>3.0.CO;2-0  1
2000 Angst J, Davidson JRT, Delini-Stula A, Van Ree JM, Van Zwieten-Boot BJ, Zohar J, Dunbar G. Post traumatic stress disorder: Guidelines for investigating efficacy of pharmacological intervention European Neuropsychopharmacology. 10: 297-303.  1
1999 Van Den Berg CL, Pijlman FTA, Koning HAM, Diergaarde L, Van Ree JM, Spruijt BM. Isolation changes the incentive value of sucrose and social behaviour in juvenile and adult rats Behavioural Brain Research. 106: 133-142. PMID 10595429 DOI: 10.1016/S0166-4328(99)00099-6  1
1999 Van Den Berg CL, Van Ree JM, Spruijt BM. Sequential analysis of juvenile isolation-induced decreased social behavior in the adult rat Physiology and Behavior. 67: 483-488. PMID 10549885 DOI: 10.1016/S0031-9384(99)00062-1  1
1999 Van den Berg CL, Van Ree JM, Spruijt BM, Kitchen I. Effects of juvenile isolation and morphine treatment on social interactions and opioid receptors in adult rats: behavioural and autoradiographic studies. The European Journal of Neuroscience. 11: 3023-32. PMID 10510167 DOI: 10.1046/j.1460-9568.1999.00717.x  1
1999 Niesink RJM, Van Buren-Van Duinkerken L, Van Ree JM. Social behavior of juvenile rats after in utero exposure to morphine: Dose-time-effect relationship Neuropharmacology. 38: 1207-1223. PMID 10462133 DOI: 10.1016/S0028-3908(99)00050-7  1
1999 Theuvenet PJ, Dunajski Z, Peters MJ, Van Ree JM. Responses to median and tibial nerve stimulation in patients with chronic neuropathic pain Brain Topography. 11: 305-313. PMID 10449261 DOI: 10.1023/A:1022210704505  1
1999 Van Berckel BNM, Evenblij CN, Van Loon BJAM, Maas MF, Van Der Geld MAM, Wynne HJ, Van Ree JM, Kahn RS. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: A double-blind, parallel, placebo-controlled study Neuropsychopharmacology. 21: 203-210. PMID 10432468 DOI: 10.1016/S0893-133X(99)00014-7  1
1999 Vos PE, Steinbusch HWM, Ronken E, Van Ree JM. Short and long term plasticity after lesioning of the cell body or terminal field area of the dopaminergic mesocorticolimbic system in the rat Brain Research. 831: 237-247. PMID 10412002 DOI: 10.1016/S0006-8993(99)01453-5  1
1999 Gerrits MAFM, Wiegant VM, Van Ree JM. Endogenous opioids implicated in the dynamics of experimental drug addiction: An in vivo autoradiographic analysis Neuroscience. 89: 1219-1227. PMID 10362309 DOI: 10.1016/S0306-4522(98)00336-4  1
1999 van Ree JM, Gerrits MA, Vanderschuren LJ. Opioids, reward and addiction: An encounter of biology, psychology, and medicine. Pharmacological Reviews. 51: 341-96. PMID 10353987  1
1999 Van den Berg CL, Kitchen I, Gerrits MA, Spruijt BM, Van Ree JM. Morphine treatment during juvenile isolation increases social activity and opioid peptides release in the adult rat. Brain Research. 830: 16-23. PMID 10350555 DOI: 10.1016/S0006-8993(99)01330-X  1
1999 Hol T, Van Den Berg CL, Van Ree JM, Spruijt BM. Isolation during the play period in infancy decreases adult social interactions in rats Behavioural Brain Research. 100: 91-97. PMID 10212056 DOI: 10.1016/S0166-4328(98)00116-8  1
1999 Oranje B, Van Berckel BNM, Kemner C, Van Ree JM, Kahn RS, Verbaten MN. P50 suppression and prepulse inhibition of the startle reflex in humans: A correlational study Biological Psychiatry. 45: 883-890. PMID 10202576 DOI: 10.1016/S0006-3223(98)00128-0  1
1999 van den Berg CL, Hol T, Van Ree JM, Spruijt BM, Everts H, Koolhaas JM. Play is indispensable for an adequate development of coping with social challenges in the rat. Developmental Psychobiology. 34: 129-38. PMID 10086231 DOI: 10.1002/(SICI)1098-2302(199903)34:2<129::AID-DEV6>3.0.CO;2-L  1
1999 Ramsey NF, Gerrits MA, Van Ree JM. Naltrexone affects cocaine self-administration in naïve rats through the ventral tegmental area rather than dopaminergic target regions. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 9: 93-9. PMID 10082233 DOI: 10.1016/S0924-977X(98)00009-1  1
1999 Cappendijk SL, Hurd YL, Nylander I, van Ree JM, Terenius L. A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides. European Journal of Pharmacology. 365: 175-82. PMID 9988100 DOI: 10.1016/S0014-2999(98)00874-7  1
1999 Van Den Brink W, Hendriks VM, Van Ree JM. Medical co-prescription of heroin to chronic, treatment-resistant methadone patients in the Netherlands Journal of Drug Issues. 29: 587-608.  1
1998 Reijmers LG, van Ree JM, Spruijt BM, Burbach JP, De Wied D. Vasopressin metabolites: a link between vasopressin and memory? Progress in Brain Research. 119: 523-35. PMID 10074810  1
1998 Popik P, van Ree JM. Neurohypophyseal peptides and social recognition in rats. Progress in Brain Research. 119: 415-36. PMID 10074804  1
1998 Kuzmin AV, Gerrits MAFM, Van Ree JM. κ-Opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats European Journal of Pharmacology. 358: 197-202. PMID 9822884 DOI: 10.1016/S0014-2999(98)00637-2  1
1998 Van Berckel BNM, Lipsch C, Gispen-de Wied C, Wynne HJ, Blankenstein MA, Van Ree JM, Kahn RS. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers Psychopharmacology. 138: 190-197. PMID 9718289 DOI: 10.1007/s002130050662  1
1998 Van Berckel BNM, Oranje B, Van Ree JM, Verbaten MN, Kahn RS. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects Psychopharmacology. 137: 271-281. PMID 9683005 DOI: 10.1007/s002130050620  1
1998 Van Den Berg CL, Lamberts RR, Wolterink G, Wiegant VM, Van Ree JM. Emotional and footshock stimuli induce differential long-lasting behavioural effects in rats; involvement of opioids Brain Research. 799: 6-15. PMID 9666058 DOI: 10.1016/S0006-8993(98)00397-7  1
1998 Hulshoff Pol HE, Hijman R, Baaré WFC, Van Ree JM. Effects of context on judgements of odor intensities in humans Chemical Senses. 23: 131-135. PMID 9589161  1
1997 Vawter MP, De Wied D, Van Ree JM. Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task. Neuropeptides. 31: 489-94. PMID 9413027  1
1997 Kuzmin AV, Gerrits MAFM, Van Ree JM, Zvartau EE. Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice Life Sciences. 60: PL-257-PL-264. PMID 9126886  1
1997 Van Berckel BNM, Lipsch C, Timp S, Wied CGd, Wynne H, Van Ree JM, Kahn RS. Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects Neuropsychopharmacology. 16: 317-324. PMID 9109102 DOI: 10.1016/S0893-133X(96)00196-0  1
1997 Kuzmin AV, Semenova S, Gerrits MAFM, Zvartau EE, Van Ree JM. κ-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice European Journal of Pharmacology. 321: 265-271. PMID 9085036 DOI: 10.1016/S0014-2999(96)00961-2  1
1997 Van Ree JM. Hersenaandoeningen vergen grote inspanningen Pharmaceutisch Weekblad. 132: 546-548.  1
1996 Niesink RJ, Vanderschuren LJ, van Ree JM. Social play in juvenile rats after in utero exposure to morphine. Neurotoxicology. 17: 905-12. PMID 9198792  1
1996 Hol T, Niesink M, Van Ree JM, Spruijt BM. Prenatal exposure to morphine affects juvenile play behavior and adult social behavior in rats Pharmacology Biochemistry and Behavior. 55: 615-618. PMID 8981592 DOI: 10.1016/S0091-3057(96)00274-2  1
1996 van Berckel BN, Hijman R, van der Linden JA, Westenberg HG, van Ree JM, Kahn RS. Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients. Biological Psychiatry. 40: 1298-300. PMID 8959296 DOI: 10.1016/S0006-3223(96)00311-3  1
1996 Kuzmin A, Semenova S, Ramsey NF, Zvartau EE, Van Ree JM. Modulation of cocaine intravenous self-administration in drug-naive animals by dihydropyridine Ca2+ channel modulators. European Journal of Pharmacology. 295: 19-25. PMID 8925870 DOI: 10.1016/0014-2999(95)00630-3  1
1996 Van Furth WR, Van Ree JM. Sexual motivation: Involvement of endogenous opioids in the ventral tegmental area Brain Research. 729: 20-28. PMID 8874873 DOI: 10.1016/S0006-8993(96)00225-9  1
1996 Van Furth WR, Van Ree JM. Appetitive sexual behavior in male rats: 2. Sexual reward and level-changing behavior Physiology and Behavior. 60: 1007-1012. PMID 8873283 DOI: 10.1016/0031-9384(96)00009-1  1
1996 Van Furth WR, Van Ree JM. Appetitive sexual behavior in male rats: 1. The role of olfaction in level-changing behavior Physiology and Behavior. 60: 999-1005. PMID 8873282 DOI: 10.1016/0031-9384(96)00010-8  1
1996 Kuzmin A, Semenova S, Zvartau EE, Van Ree JM. Enhancement of morphine self-administration in drug naive, inbred strains of mice by acute emotional stress European Neuropsychopharmacology. 6: 63-68. PMID 8866940 DOI: 10.1016/0924-977X(95)00066-X  1
1996 Buitelaar JK, Dekker ME, van Ree JM, van Engeland H. A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 6: 13-9. PMID 8866933 DOI: 10.1016/0924-977X(95)00049-U  1
1996 Popik P, Vetulani J, Van Ree JM. Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides. European Journal of Pharmacology. 308: 113-6. PMID 8840121 DOI: 10.1016/0014-2999(96)00215-4  1
1996 Van Ree JM. Endorphins and experimental addiction Alcohol. 13: 25-30. PMID 8837930 DOI: 10.1016/0741-8329(95)02036-5  1
1996 Verbaten MN, Kemner C, Buitelaar JK, van Ree JM, van Beijsterveld CE, van Engeland H. Effects of ORG-2766 on brain event-related potentials of autistic children. Psychiatry Research. 63: 33-45. PMID 8832772 DOI: 10.1016/0165-1781(96)89319-X  1
1996 Hol T, Ruven S, Van Ree JM, Spruijt BM. Chronic administration of Org2766 and morphine counteracts isolation- induced increase in social interest: Implication of endogenous opioid systems Neuropeptides. 30: 283-291. PMID 8819152 DOI: 10.1016/S0143-4179(96)90074-8  1
1996 Mulder AB, Manshanden I, Vos PE, Wolterink G, van Ree JM, Lopes da Silva FH. Modifications in glutamatergic transmission after dopamine depletion of the nucleus accumbens. A combined in vivo/in vitro electrophysiological study in the rat. Neuroscience. 72: 1009-21. PMID 8735226 DOI: 10.1016/0306-4522(96)00035-8  1
1996 Gerrits MAFM, Van Ree JM. Effect of nucleus accumbens dopamine depletion on motivational aspects involved in initiation of cocaine and heroin self-administration in rats Brain Research. 713: 114-124. PMID 8724982 DOI: 10.1016/0006-8993(95)01491-8  1
1996 Vos PE, Steinbusch HWM, Van Ree JM. Reinnervation after destruction of the dopaminergic system in the rat nucleus accumbens: A quantitative immunohistochemical analysis Neuroscience Letters. 207: 21-24. PMID 8710200 DOI: 10.1016/0304-3940(96)12498-8  1
1996 Van Ree JM. Neuropeptides: Targets for antidepressants? European Neuropsychopharmacology. 6: 3-4.  1
1995 Kok FW, Westenberg HGM, Thijssen JHH, van Ree JM. Endocrine and cardiovascular responses to a series of graded physical and psychological stress stimuli in healthy volunteers European Neuropsychopharmacology. 5: 515-522. PMID 8998405 DOI: 10.1016/0924-977X(95)80012-Q  1
1995 Vos PE, Wolterink G, van Ree JM. The behavioral effects of habituation and challenge with apomorphine after 6-OHDA lesioning of the nucleus accumbens in rats European Neuropsychopharmacology. 5: 471-476. PMID 8998399 DOI: 10.1016/0924-977X(95)80006-N  1
1995 van Furth WR, Wolterink G, van Ree JM. Regulation of masculine sexual behavior: involvement of brain opioids and dopamine Brain Research Reviews. 21: 162-184. PMID 8866673 DOI: 10.1016/0165-0173(96)82985-7  1
1995 Vanderschuren LJ, Spruijt BM, Hol T, Niesink RJ, Van Ree JM. Sequential analysis of social play behavior in juvenile rats: effects of morphine. Behavioural Brain Research. 72: 89-95. PMID 8788861 DOI: 10.1016/0166-4328(96)00060-5  1
1995 Hatta K, Wolterink G, Van Ree JM. Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and β-endorphin-(10-16), like antidepressants, antagonize melatonin-induced behavioural changes in rats European Journal of Pharmacology. 284: 327-330. PMID 8666016 DOI: 10.1016/0014-2999(95)00473-X  1
1995 Kok FW, Heijnen CJ, Bruijn JA, Westenberg HGM, van Ree JM. Immunoglobulin production in vitro in major depression: A pilot study on the modulating action of endogenous cortisol Biological Psychiatry. 38: 217-226. PMID 8547443 DOI: 10.1016/0006-3223(94)00297-G  1
1995 Van Ree JM. The pharmacology of addiction | DE FARMACOLOGIE VAN VERSLAVING Nederlands Tijdschrift Voor Geneeskunde. 139: 2610-2613. PMID 8544882  1
1995 Hulshoff Pol HE, Baaré WF, Mali WP, van Ree JM, Kahn RS. Schizophrenia in clinical imaging; anomalies in brain anatomy and metabolism | Schizofenie in beeld gebracht; afwijkingen in hersenanatomie en -metabolisme Nederlands Tijdschrift Voor Geneeskunde. 139: 494-497. PMID 7891755  1
1995 Bruins J, Hijman R, Van Ree JM. Effect of acute and chronic treatment with desglycinamide-[Arg8]vasopressin in young male and female volunteers Peptides. 16: 179-186. PMID 7784246 DOI: 10.1016/0196-9781(94)00193-6  1
1995 Vanderschuren LJ, Niesink RJ, Spruijt BM, Van Ree JM. Effects of morphine on different aspects of social play in juvenile rats. Psychopharmacology. 117: 225-31. PMID 7753971 DOI: 10.1007/BF02245191  1
1995 Van Furth WR, Van Emst MG, Van Ree JM. Opioids and sexual behavior of male rats: Involvement of the medial preoptic area Behavioral Neuroscience. 109: 123-134. PMID 7734068 DOI: 10.1037/0735-7044.109.1.123  1
1995 Gerrits MAFM, van Ree JM, Patkina N, Zvartau EE. Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats Psychopharmacology. 119: 92-98. PMID 7675956 DOI: 10.1007/BF02246059  1
1995 Vanderschuren LJ, Niesink RJ, Spruijt BM, Van Ree JM. Influence of environmental factors on social play behavior of juvenile rats. Physiology & Behavior. 58: 119-23. PMID 7667408 DOI: 10.1016/0031-9384(94)00385-I  1
1995 Vanderschuren LJ, Stein EA, Wiegant VM, Van Ree JM. Social play alters regional brain opioid receptor binding in juvenile rats. Brain Research. 680: 148-56. PMID 7663971 DOI: 10.1016/0006-8993(95)00256-P  1
1995 Vanderschuren LJ, Niesink RJ, Spruijt BM, Van Ree JM. Mu- and kappa-opioid receptor-mediated opioid effects on social play in juvenile rats. European Journal of Pharmacology. 276: 257-66. PMID 7601211 DOI: 10.1016/0014-2999(95)00040-R  1
1995 Van Ree JM, Wolterink G, Igarashi Y, Vanderschuren L, Wiegant VM, Rust CJ, Bruning HW. Behavioral studies on the putative gamma-type endorphin receptor using different antibodies. European Journal of Pharmacology. 279: 187-96. PMID 7556400 DOI: 10.1016/0014-2999(95)00157-G  1
1995 Vanderschuren LJ, Stein EA, Wiegant VM, Van Ree JM. Social isolation and social interaction alter regional brain opioid receptor binding in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 119-27. PMID 7549454 DOI: 10.1016/0924-977X(95)00010-M  1
1995 Gerrits MAFM, van Ree JM. Assessment of motivational aspects involved in initiation of cocaine and heroin self-administration in rats Pharmacology, Biochemistry and Behavior. 52: 35-42. PMID 7501676 DOI: 10.1016/0091-3057(95)00112-A  1
1995 Vawter MP, van Ree JM. Effects of des-glycinamide9-[arginine8] vasopressin upon spatial memory in the hole-board search task Psychobiology. 23: 45-51. DOI: 10.3758/BF03327057  1
1994 van Furth WR, van Ree JM. Endogenous opioids and sexual motivation and performance during the light phase of the diurnal cycle Brain Research. 636: 175-179. PMID 8156406 DOI: 10.1016/0006-8993(94)90196-1  1
1994 Van Furth WR, Wolterink-Donselaar IG, Van Ree JM. Endogenous opioids are differentially involved in appetitive and consummatory aspects of sexual behavior of male rats American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 266: R606-R613. PMID 8141421  1
1994 van Ree JM, Kornet M, Goosen C. Neuropeptides and alcohol addiction in monkeys Exs. 71: 165-174. PMID 8032147  1
1994 Westenberg HGM, Hijman R, Wiegant VM, Laczi F, Van Ree JM. Pharmacokinetics of DGAVP in plasma following intranasal and oral administration to healthy subjects Peptides. 15: 1101-1104. PMID 7991455 DOI: 10.1016/0196-9781(94)90077-9  1
1994 Radhakishun FS, Westerink BHC, Stoof JC, Wolterink G, van Ree JM. Subchronic treatment with the neuroleptic-like peptide desenkephalin- γ-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of rats European Neuropsychopharmacology. 4: 127-136. PMID 7919942 DOI: 10.1016/0924-977X(94)90006-X  1
1994 Gerrits MA, Ramsey NF, Wolterink G, van Ree JM. Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat. Psychopharmacology. 114: 486-94. PMID 7855207 DOI: 10.1007/BF02249340  1
1994 van Ree JM, Ramsey NF, Gerrits M. Endorphins, emotional stress and experimental cocaine addiction European Neuropsychopharmacology. 4: 208-210. DOI: 10.1016/0924-977X(94)90043-4  1
1994 Wolterink G, van Ree JM. Interactions between γ-type endorphins and brain dopamine systems European Neuropsychopharmacology. 4: 176-177. DOI: 10.1016/0924-977X(94)90021-3  1
1994 van Ree JM. Neuropeptides and psychopathology Journal of Controlled Release. 29: 307-315. DOI: 10.1016/0168-3659(94)90076-0  1
1994 Vanderschuren LJMJ, Van Ree JM. Multiple effects of morphine on social play Regulatory Peptides. 53: S229-S230. DOI: 10.1016/0167-0115(94)90324-7  1
1994 Van Berckel BNM, Van Ree JM, Kahn RS. Non-monoaminergic systems in schizophrenia | NON-MONOAMINERGE SYSTEMEN BIJ SCHIZOFRENIE Tijdschrift Voor Psychiatrie. 36: 762-775.  1
1993 Ramsey NF, Van Ree JM. Emotional but not physical stress enhances intravenous cocaine self-administration in drug-naive rats. Brain Research. 608: 216-22. PMID 8495356 DOI: 10.1016/0006-8993(93)91461-Z  1
1993 Popik P, Van Ree JM. Social transmission of flavored tea preferences: facilitation by a vasopressin analog and oxytocin. Behavioral and Neural Biology. 59: 63-8. PMID 8442734 DOI: 10.1016/0163-1047(93)91173-K  1
1993 Ramsey NF, Niesink RJ, Van Ree JM. Prenatal exposure to morphine enhances cocaine and heroin self-administration in drug-naive rats. Drug and Alcohol Dependence. 33: 41-51. PMID 8396529 DOI: 10.1016/0376-8716(93)90032-L  1
1993 Gispen-de Wied CC, D'Haenen H, Verhoeven WMA, Wynne HJ, Westenberg HGM, Thijssen JH, Van Ree JM. Inhibition of the pituitary-adrenal axis with dexamethasone and cortisol in depressed patients and healthy subjects: A dose-response study Psychoneuroendocrinology. 18: 191-204. PMID 8390700 DOI: 10.1016/0306-4530(93)90004-5  1
1993 Leeuwen JHSv, Te Velde ER, Koppeschaar HPF, Kop WJ, Thijssen JHH, Van Ree JM, Haspels AA. Is premenstrual syndrome an endocrine disorder? Journal of Psychosomatic Obstetrics and Gynecology. 14: 91-109. PMID 8358530 DOI: 10.3109/01674829309084433  1
1993 Kusse MC, van Nieuwenhuizen O, van Huffelen AC, van der Mey W, Thijssen JH, van Ree JM. The effect of non-depot ACTH(1-24) on infantile spasms. Developmental Medicine and Child Neurology. 35: 1067-73. PMID 8253287  1
1993 Wied CCGd, Kok FW, Koppeschaar HPF, Wynne HJ, Westenberg HGM, Thijssen JHH, van Ree JM. Stimulation of the pituitary-adrenal system with graded doses of CRH and low dose vasopressin infusion in depressed patients and healthy subjects: a pilot study European Neuropsychopharmacology. 3: 533-541. PMID 8111227 DOI: 10.1016/0924-977X(93)90279-U  1
1993 Wolterink G, van Ree JM. Long-term disruption of intracranial self-stimulation behaviour by lesion of the nucleus accumbens dopamine system: effect of ORG 2766 treatment European Neuropsychopharmacology. 3: 438-439. DOI: 10.1016/0924-977X(93)90240-M  1
1993 van Ree JM. Opiate antagonists and addiction European Neuropsychopharmacology. 3: 223-224. DOI: 10.1016/0924-977X(93)90037-M  1
1993 Popik P, Vetulani J, van Ree JM. Social memory and neurohypophyseal hormones European Neuropsychopharmacology. 3: 200-201. DOI: 10.1016/0924-977X(93)90024-G  1
1993 Wolterink G, Vos PE, van Ree JM. ACTH neuropeptides and recovery after brain damage European Neuropsychopharmacology. 3: 198-199. DOI: 10.1016/0924-977X(93)90023-F  1
1992 Popik P, Vos PE, Van Ree JM. Neurohypophyseal hormone receptors in the septum are implicated in social recognition in the rat. Behavioural Pharmacology. 3: 351-358. PMID 11224137  1
1992 Popik P, Vetulani J, van Ree JM. Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology. 106: 71-4. PMID 1738795 DOI: 10.1007/BF02253591  1
1992 Popik P, Van Ree JM. Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study. Life Sciences. 50: 567-72. PMID 1736027 DOI: 10.1016/0024-3205(92)90368-Y  1
1992 Kornet M, Goosen C, Van Ree JM. Opioid modulation of alcohol intake in monkeys by low doses of naltrexone and morphine Annals of the New York Academy of Sciences. 654: 469-471. PMID 1632606  1
1992 Ramsey NF, Van Ree JM. Reward and abuse of opiates. Pharmacology & Toxicology. 71: 81-94. PMID 1438034  1
1992 Buitelaar JK, van Engeland H, de Kogel K, de Vries H, van Hooff J, van Ree J. The adrenocorticotrophic hormone (4-9) analog ORG 2766 benefits autistic children: report on a second controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry. 31: 1149-56. PMID 1331023  1
1992 Buitelaar JK, van Engeland H, de Kogel KH, de Vries H, van Hooff JA, van Ree JM. The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior. Biological Psychiatry. 31: 1119-29. PMID 1326339 DOI: 10.1016/0006-3223(92)90156-T  1
1992 Buitelaar JK, van Engeland H, de Kogel CH, de Vries H, van Hooff JA, van Ree JM. Deficits in social behavior in autism and their modification by a synthetic adrenocorticotrophic hormone (4-9) analog. Experientia. 48: 391-4. PMID 1316288 DOI: 10.1007/BF01923438  1
1992 van Ree JM, Gerrits M, Ramsey NF. The involvement of endorphins and dopamine in experimental addiction European Neuropsychopharmacology. 2: 219-221. DOI: 10.1016/0924-977X(92)90074-I  1
1992 Hijman R, Jolles J, Verhoeven WMA, Van Ree JM, Elderson A, De Wied D. Desglycinamide-(Arg8)-vasopressin in five trials with memory-disturbed patients Human Psychopharmacology. 7: 7-23.  1
1991 Popik P, Wolterink G, De Brabander H, van Ree JM. Neuropeptides related to [Arg8]vasopressin facilitates social recognition in rats. Physiology & Behavior. 49: 1031-5. PMID 1896485 DOI: 10.1016/0031-9384(91)90327-K  1
1991 Wolterink G, van Ree JM, van Nispen JW, de Wied D. Structural modifications of the ACTH-(4-9) analog ORG 2766 yields peptides with high biological activity. Life Sciences. 48: 155-61. PMID 1847225 DOI: 10.1016/0024-3205(91)90409-5  1
1991 Popik P, Vetulani J, Bisaga A, van Ree JM. Recognition cue in the rat's social memory paradigm. Journal of Basic and Clinical Physiology and Pharmacology. 2: 315-27. PMID 1822146 DOI: 10.1515/JBCPP.1991.2.4.315  1
1991 Ramsey NF, van Ree JM. Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats. Pharmacology, Biochemistry, and Behavior. 40: 807-10. PMID 1816567 DOI: 10.1016/0091-3057(91)90090-O  1
1991 Popik P, van Ree JM. Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 1: 555-60. PMID 1668316 DOI: 10.1016/0924-977X(91)90010-R  1
1990 Buitelaar JK, van Engeland H, van Ree JM, de Wied D. Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4-9), in 14 outpatient autistic children. Journal of Autism and Developmental Disorders. 20: 467-78. PMID 2177746 DOI: 10.1007/BF02216053  1
1990 Ramsey NF, van Ree JM. Chronic pretreatment with naltrexone facilitates acquisition of intravenous cocaine self-administration in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 1: 55-61. PMID 2136215 DOI: 10.1016/0924-977X(90)90012-Y  1
1989 Kovács GL, Liu B, Burbach JP, Van Ree JM, De Wied D. N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin. European Journal of Pharmacology. 161: 27-35. PMID 2721547 DOI: 10.1016/0014-2999(89)90176-3  1
1989 de Wied D, van Ree JM. Neuropeptides: animal behaviour and human psychopathology. European Archives of Psychiatry and Neurological Sciences. 238: 323-31. PMID 2670577 DOI: 10.1007/BF00449813  1
1987 de Wied D, Gaffori O, Burbach JP, Kovács GL, van Ree JM. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. The Journal of Pharmacology and Experimental Therapeutics. 241: 268-74. PMID 3572787  1
1987 Laczi F, László FA, Kovács GL, Telegdy G, Szász A, Szilárd J, van Ree JM, de Wied D. Differential effect of desglycinamide9-(Arg8)-vasopressin on cognitive functions of diabetes insipidus and alcoholic patients. Acta Endocrinologica. 115: 392-8. PMID 3303787  1
1987 De Wied D, Van Ree JM. Non-opiate effects of neuropeptides derived from beta-endorphin. Polish Journal of Pharmacology and Pharmacy. 39: 623-32. PMID 2976164  1
1987 van Ree JM, Verhoeven WM, de Wied D. Animal and clinical research on neuropeptides and schizophrenia. Progress in Brain Research. 72: 249-67. PMID 2441432  1
1986 Drago F, Van Ree JM, De Wied D. Desenkephalin-gamma-endorphin restores the impaired sensitivity of hypophysectomized rats to small doses of apomorphine. European Journal of Pharmacology. 128: 205-12. PMID 3792442 DOI: 10.1016/0014-2999(86)90767-3  1
1986 Fekete M, Van Ree JM, De Wied D. The ACTH-(4-9) analog ORG 2766 and desglycinamide9-(Arg8)-vasopressin reverse the retrograde amnesia induced by disrupting circadian rhythms in rats. Peptides. 7: 563-8. PMID 3020524  1
1986 Drago F, Bohus B, Bitetti R, Scapagnini U, van Ree JM, de Wied D. Intracerebroventricular injection of anti-prolactin serum suppresses excessive grooming of pituitary homografted rats. Behavioral and Neural Biology. 46: 99-105. PMID 3015122 DOI: 10.1016/0196-9781(84)90008-1  1
1986 van Ree JM, Verhoeven WM, Claas FH, de Wied D. Antipsychotic action of gamma-type endorphins: animal and human studies. Progress in Brain Research. 65: 221-35. PMID 2431435 DOI: 10.1016/S0079-6123(08)60653-6  1
1986 Claas FH, van Ree JM, Verhoeven WM, van der Poel JJ, Verduyn W, de Wied D, van Rood JJ. The interaction between gamma-type endorphins and HLA class I antigens. Human Immunology. 15: 347-56. PMID 2422143  1
1985 Fekete M, van Ree JM, Niesink RJ, de Wied D. Disrupting circadian rhythms in rats induces retrograde amnesia. Physiology & Behavior. 34: 883-7. PMID 4059376 DOI: 10.1016/0031-9384(85)90008-3  1
1985 Van Ree JM, Hijman R, Jolles J, De Wied D. Vasopressin and related peptides: animal and human studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 551-9. PMID 3911283 DOI: 10.1016/0278-5846(85)90016-8  1
1985 van Ree JM, de Wied D. Behavioral effects of non-opioid fragments of beta-endorphin. Progress in Clinical and Biological Research. 192: 277-84. PMID 2934744  1
1985 Van Ree JM, Verhoeven WM, De Wied D. Gamma-type endorphins: neurolepticum-like and antipsychotic action. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 561-7. PMID 2418467 DOI: 10.1016/0278-5846(85)90017-X  1
1984 de Wied D, Gaffori O, van Ree JM, de Jong W. Central target for the behavioural effects of vasopressin neuropeptides. Nature. 308: 276-8. PMID 6322010  1
1984 Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia. Psychiatry Research. 11: 329-46. PMID 6204351 DOI: 10.1016/0165-1781(84)90006-4  1
1984 van Ree JM, Verhoeven WM, Brouwer GJ, de Wied D. Ceruletide resembles antipsychotics in rats and schizophrenic patients. Preliminary report. Neuropsychobiology. 12: 4-8. PMID 6151145  1
1984 De Wied D, Gaffori O, Van Ree JM, De Jong W. Vasopressin antagonists block peripheral as well as central vasopressin receptors. Pharmacology, Biochemistry, and Behavior. 21: 393-400. PMID 6093152  1
1983 Laczi F, van Ree JM, Wagner A, Valkusz Z, Járdánházy T, Kovács GL, Telegdy G, Szilárd J, László FA, de Wied D. Effects of desglycinamide-arginine-vasopressin (DG-AVP) on memory processes in diabetes insipidus patients and non-diabetic subjects. Acta Endocrinologica. 102: 205-12. PMID 6829260  1
1983 van Wimersma Greidanus TB, van Ree JM, de Wied D. Vasopressin and memory. Pharmacology & Therapeutics. 20: 437-58. PMID 6351117 DOI: 10.1016/0163-7258(83)90036-0  1
1983 Fekete M, Drago F, Van Ree JM, Bohus B, Wiegant VM, De Wied D. Naltrexone-sensitive behavioral actions of the ACTH 4-9 analog (Org 2766). Life Sciences. 32: 2193-204. PMID 6302425 DOI: 10.1016/0024-3205(83)90417-4  1
1983 Van Ree JM, Gaffori O, De Wied D. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents. European Journal of Pharmacology. 93: 63-78. PMID 6138272 DOI: 10.1016/0014-2999(83)90031-6  1
1983 Serra G, Van Ree JM, de Wied D. Influence of classical and atypical neuroleptics on apomorphine-induced behavioural changes and on extinction of a conditioned avoidance response. The Journal of Pharmacy and Pharmacology. 35: 255-7. PMID 6133940  1
1982 de Jongh BM, Verhoeven WM, van Ree JM, de Wied D, van Rood JJ. Hla, and the response to treatment with gamma-type endorphins in schizophrenia. Journal of Immunogenetics. 9: 381-8. PMID 6186747  1
1982 Nijkamp FP, van Ree JM, Nijssen JG, Versluis M, de Wied D. Opposite interactions between alpha- and beta-endorphin fragments with dopamine mediated responses on the rat rectum in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 213-7. PMID 6185856 DOI: 10.1007/BF00505488  1
Show low-probability matches.